In the third episode of the three-part podcast series by Adams & Adams on the IP enforcement of pharma in Africa, partners Danie Dohmen and Russell Bagnall, and in-house counsel Natasha Wright, talk to Managing IP about recent trends in pharmaceutical patent litigation in South Africa.

The experts discuss the nuances of the enforcement environment in South Africa amid the COVID-19 pandemic, specific pharma litigation enforcement proceedings, and the impact of the non-examination of patents, while providing examples to assist business leaders, innovators and consumers who work in the South African IP field.